Michael Ross, MD | |
515 W Mayfield Rd Ste 102, Arlington, TX 76014-2084 | |
(817) 759-7000 | |
(817) 759-7027 |
Full Name | Michael Ross |
---|---|
Gender | Male |
Speciality | Medical Oncology |
Experience | 53 Years |
Location | 515 W Mayfield Rd Ste 102, Arlington, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1821048323 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RH0003X | Internal Medicine - Hematology & Oncology | F5349 (Texas) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Oncology-hematology Consultants Pa | 5496646382 | 56 |
News Archive
Huifeng Bio-Pharmaceutical Technology, Inc., a leading developer and producer of plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production, today reported that after preliminary due diligence, including review of the company's market potential and development opportunities, EquityNet Research is initiating coverage of the company as an independent analyst.
Cancer Research UK scientists have revealed how a combination of two very different drugs - currently being tested in clinical trials - amplifies the destruction of pancreatic cancer cells, according to research published in the Journal of Experimental Medicine, today.
Bausch + Lomb, the global eye health company, today announced it has acquired 100 percent of the outstanding shares of Laboratorio Pfortner Cornealent SACIF, the controlling entity of Waicon.
For most people with Parkinson's disease, the only relief from the tremors, rigidity and impaired movement associated with the progressive loss of their motor skills is a drug called L-DOPA. But as the disease progresses, L-DOPA can cause prominent side effects that counteract its effectiveness.
› Verified 2 days ago
Entity Name | Oncology-hematology Consultants Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1629021159 PECOS PAC ID: 5496646382 Enrollment ID: O20040322000664 |
News Archive
Huifeng Bio-Pharmaceutical Technology, Inc., a leading developer and producer of plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production, today reported that after preliminary due diligence, including review of the company's market potential and development opportunities, EquityNet Research is initiating coverage of the company as an independent analyst.
Cancer Research UK scientists have revealed how a combination of two very different drugs - currently being tested in clinical trials - amplifies the destruction of pancreatic cancer cells, according to research published in the Journal of Experimental Medicine, today.
Bausch + Lomb, the global eye health company, today announced it has acquired 100 percent of the outstanding shares of Laboratorio Pfortner Cornealent SACIF, the controlling entity of Waicon.
For most people with Parkinson's disease, the only relief from the tremors, rigidity and impaired movement associated with the progressive loss of their motor skills is a drug called L-DOPA. But as the disease progresses, L-DOPA can cause prominent side effects that counteract its effectiveness.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Michael Ross, MD 800 W Magnolia Ave, Fort Worth, TX 76104-4611 Ph: () - | Michael Ross, MD 515 W Mayfield Rd Ste 102, Arlington, TX 76014-2084 Ph: (817) 759-7000 |
News Archive
Huifeng Bio-Pharmaceutical Technology, Inc., a leading developer and producer of plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production, today reported that after preliminary due diligence, including review of the company's market potential and development opportunities, EquityNet Research is initiating coverage of the company as an independent analyst.
Cancer Research UK scientists have revealed how a combination of two very different drugs - currently being tested in clinical trials - amplifies the destruction of pancreatic cancer cells, according to research published in the Journal of Experimental Medicine, today.
Bausch + Lomb, the global eye health company, today announced it has acquired 100 percent of the outstanding shares of Laboratorio Pfortner Cornealent SACIF, the controlling entity of Waicon.
For most people with Parkinson's disease, the only relief from the tremors, rigidity and impaired movement associated with the progressive loss of their motor skills is a drug called L-DOPA. But as the disease progresses, L-DOPA can cause prominent side effects that counteract its effectiveness.
› Verified 2 days ago
Dr. Waldo P Bracy Jr., M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1001 N Waldrop Dr, Ste. 509, Arlington, TX 76012 Phone: 817-394-4300 Fax: 817-394-0200 | |
Thang D Le, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 800 W Randol Mill Rd Ste 2300, Arlington, TX 76012 Phone: 866-202-1032 Fax: 817-548-6649 | |
Dr. Hujefa Yusuf Vora, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3150 Matlock Rd, Suite 403, Arlington, TX 76015 Phone: 817-784-0052 Fax: 817-375-5800 | |
Dr. Raza Askari, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 515 W Mayfield Rd Ste 210, Arlington, TX 76014 Phone: 817-375-5847 | |
Thuc Quyen Thi Nguyen, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 515 W Mayfield Rd, Suite 210, Arlington, TX 76014 Phone: 817-417-4027 Fax: 817-417-4043 | |
Dr. Bienvenido Gatmaitan Gatmaitan, Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 621 Matlock Centre Cir, Arlington, TX 76015 Phone: 817-860-6062 Fax: 817-795-6652 | |
Bernard A Mcgowen, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1217 Florida Dr, Suite 121, Arlington, TX 76015 Phone: 817-419-9155 Fax: 817-419-9412 |